[1]
|
Huang, J.J., Chan, P.S., Lok, V., Chen, X., Ding, H.Y., Jin, Y.Z., Yuan, J.Q. and Lao, X.-Q. (2021) Global Incidence and Mortality of Breast Cancer: A Trend Analysis. Aging (Albany NY), 13, 5748-5803.
https://doi.org/10.18632/aging.202502
|
[2]
|
Sung, H. (2021) Global Cancer Statistics 2020: GLOBOCAN Esti-mates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[3]
|
中国年轻乳腺癌诊疗与生育管理专家共识专家委员会. 年轻乳腺癌诊疗与生育管理专家共识[J]. 中华肿瘤杂志, 2019, 41(7): 486-495.
|
[4]
|
Ribnikar, D. and Ribeiro, J.M. (2015) Breast Cancer under Age 40: A Different Approach. Current Treatment Options in Oncology, 16, Article No. 334. https://doi.org/10.1007/s11864-015-0334-8
|
[5]
|
Johansson Anna, L.V. (2019) Breast Cancer-Specific Sur-vival by Clinical Subtype after 7 Years Follow-Up of Young and Elderly Women in a Nationwide Cohort. International Journal of Cancer, 144, 1251-1261.
https://doi.org/10.1002/ijc.31950
|
[6]
|
赵建芳, 李延新. 年轻乳腺癌患者与中老年乳腺癌患者在临床病理中的差异对比[J]. 延安大学学报(医学科学版), 2018, 16(2): 65-67.
|
[7]
|
Eiriz, I.F., Vaz Batista, M., Cruz Tomás, T., Neves, M.T., Guerra-Pereira, N. and Braga, S. (2021) Breast Cancer in Very Young Women—A Multicenter 10-Year Experience. ESMO Open, 6, Article ID: 100029.
https://doi.org/10.1016/j.esmoop.2020.100029
|
[8]
|
中国抗癌协会乳腺癌专业委员会. 中国乳腺癌筛查与早期诊断指南[J]. 中国癌症杂志, 2022, 32(4): 363-372.
|
[9]
|
杨晶, 黄安茜, 谭艳娟, 朱罗茜, 包凌云. 超声多模态在年轻乳腺癌中的诊断价值[J]. 浙江中西医结合杂志, 2021, 31(12): 1144-1146, 1182.
|
[10]
|
乌兰, 陈宁, 朱晓龙. X线钼靶、CT检测及超声检测致密型腺体乳腺癌早期诊断中的应用价值对比[J]. 中国CT和MRI杂志, 2021, 19(10): 87-90.
|
[11]
|
吴丽伟. 超声诊断技术在乳腺癌早期诊断中的应用及准确性分析[J]. 影像研究与医学应用, 2022, 6(9): 148-150.
|
[12]
|
汪瑞, 周军, 沈俊, 董天赋, 王培顺, 高希涛, 李淑琴, 王岩, 王昭昕. 核磁共振成像, X线钼靶及彩色超声在乳腺癌早期诊断中的应用价值分析[J]. 世界最新医学信息文摘, 2017, 17(75): 128-129.
|
[13]
|
王鑫. 青年乳腺癌临床病理特点分子分型及预后分析[J]. 现代诊断与治疗, 2020, 31(22): 3603-3605.
|
[14]
|
Zhong, W.J., Tan, L.Y., Jiang, W.G., Chen, K., You, N., Sanders, A.J., Liang, G.H. and Liu, Z.H. (2019) Effect of Younger Age on Survival Outcomes in T1N0M0 Breast Cancer: A Propensity Score Matching Analysis. Journal of Surgical On-cology, 119, 1039-1046. https://doi.org/10.1002/jso.25457
|
[15]
|
Anders, C.K., Fan, C., Parker, J.S., Carey, L.A., Blackwell, K.L. and Klauber-DeMore, N. (2011) Breast Carcinomas Arising at a Young Age: Unique Biology or a Sur-rogate for Aggressive Intrinsic Subtypes? Journal of Clinical Oncology, 29, e18-e20. https://doi.org/10.1200/JCO.2010.28.9199
|
[16]
|
Yang, Y.P., Wei, W.D., Jin, L., He, H.Y., Wei, M.N., Shen, S.Y., Pi, H., Liu, Z.Q. and Li, H.Y. (2022) Comparison of the Characteristics and Prognosis between Very Young Women and Older Women with Breast Cancer: A Multi-Institutional Report From China. Frontiers in Oncology, 12, Article ID: 783487.
https://doi.org/10.3389/fonc.2022.783487
|
[17]
|
李宏, 胡波. 探讨超声引导下粗针穿刺活检在乳腺癌诊疗中的应用价值[J]. 中国医药指南, 2020, 18(32): 32-34.
|
[18]
|
Perou, C.M., Sørlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T. and Johnsen, H. (2000) Molecular Portraits of Human Breast Tumours. Na-ture, 406, 747-752. https://doi.org/10.1038/35021093
|
[19]
|
Goldhirsch, A., Winer, E.P., Coates, A.S., Gelber, R.D., Piccart-Gebhart, M., Thürlimann, B. and Senn, H.-J. (2013) Personalizing the Treatment of Women with Early Breast Cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Annals of Oncology, 24, 2206-2223.
|
[20]
|
Coates, A.S., Winer, E.P., Goldhirsch, A., Gelber, R.D., Gnant, M., Pic-cart-Gebhart, M., Thürlimann, B. and Senn, H.-J. (2015) Tailoring Therapies—Improving the Management of Early Breast Cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Annals of Oncology, 26, 1533-1546.
|
[21]
|
冷茹冰, 张新阁, 周红艳, 李娜. 不同分子分型乳腺癌的临床病理特征及预后危险因素分析[J]. 临床医学, 2021, 41(5): 8-10.
|
[22]
|
Ehinger, A., Malmström, P., Bendahl, P.-O., Elston, C.W., Falck, A.-K. and Forsare, C. (2017) Histological Grade Provides Significant Prognostic Information in Addition to Breast Can-cer Subtypes Defined According to St Gallen 2013. Acta Oncologica, 56, 68-74. https://doi.org/10.1080/0284186X.2016.1237778
|
[23]
|
Xue, C., Wang, X., Peng, R.J., Shi, Y.X., Qin, T., Liu, D.G., Teng, X.Y., Wang, S.S. and Zhang, L. (2012) Distribution, Clinicopathologic Features and Survival of Breast Cancer Subtypes in Southern China. Cancer Science, 103, 1679-1687.
https://doi.org/10.1111/j.1349-7006.2012.02339.x
|
[24]
|
吕爱红. 浅谈年轻女性乳腺癌的临床病理特征及分子分型[J]. 世界复合医学, 2018, 4(3): 5-7.
|
[25]
|
Maffuz-Aziz, A., Labastida-Almendaro, S., Espejo-Fonseca, A. and Rodríguez-Cuevas, S. (2017) Clinical and Pathological Features of Breast Cancer in a Population of Mexico. Cirugía y Cirujanos, 85, 201-207.
https://doi.org/10.1016/j.circen.2017.05.010
|
[26]
|
胡震, 朱信屹. 乳腺癌的预防[J]. 实用肿瘤杂志, 2016, 31(5): 409-414.
|
[27]
|
Kolak, A., Kamińska, M., Sygit, K., Budny, A. and Surdyka, D. (2017) Primary and Secondary Preven-tion of Breast Cancer. Annals of Agricultural and Environmental Medicine, 24, 549-553. https://doi.org/10.26444/aaem/75943
|
[28]
|
Sellami, M. and Bragazzi, N.L. (2020) Nutrigenomics and Breast Cancer: State-of-Art, Future Perspectives and Insights for Prevention. Nutrients, 12, Article No. 512. https://doi.org/10.3390/nu12020512
|
[29]
|
Feng, F., Wei, Y.X., Zheng, K., Li, Y.J., Zhang, L., Wang, T.L., Zhang, Y.L. and Li, H.Y. (2018) Comparison of Epidemiological Features, Clinicopathological Features, and Treatments be-tween Premenopausal and Postmenopausal Female Breast Cancer Patients in Western China: A Retrospective Multicenter Study of 15,389 Female Patients. Cancer Medicine, 7, 2753-2763. https://doi.org/10.1002/cam4.1503
|
[30]
|
Borges, V.F., Lyons, T.R., Germain, D. and Schedin, P. (2020) Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments? Cancer Research, 80, 1790-1798.
https://doi.org/10.1158/0008-5472.CAN-19-3448
|
[31]
|
李培, 吴炅. 中国乳腺癌外科治疗现状和新趋势[J]. 中国肿瘤临床, 2022, 49(22): 1151-1155.
|
[32]
|
Komoike, Y., Akiyama, F., Iino, Y., Ikeda, T., Akashi-Tanaka, S. and Ohsumi, S. (2006) Ipsilateral Breast Tumor Recurrence (IBTR) after Breast-Conserving Treatment for Early Breast Can-cer: Risk Factors and Impact on Distant Metastases. Cancer, 106, 35-41. https://doi.org/10.1002/cncr.21551
|
[33]
|
Litière, S., Werutsky, G., Fentiman, I.S., Rutgers, E. and Christiaens, M.-R. (2012) Breast Conserving Therapy versus Mastectomy for Stage I-II Breast Cancer: 20 Year Follow-Up of the EORTC 10801 Phase 3 Randomised Trial. The Lancet Oncology, 13, 412-419. https://doi.org/10.1016/S1470-2045(12)70042-6
|
[34]
|
Lowery, A.J., Kell, M.R., Glynn, R.W., Kerin, M.J. and Sweeney, K.J. (2012) Locoregional Recurrence after Breast Cancer Surgery: A Systematic Review by Receptor Pheno-type. Breast Cancer Research and Treatment, 133, 831-841.
https://doi.org/10.1007/s10549-011-1891-6
|
[35]
|
Peyroteo, M., Canotilho, R., Correia, A.M., Baía, C., Ribeiro, C. and Reis, P. (2022) Predictive Factors of Non-Sentinel Lymph Node Disease in Breast Cancer Patients with Positive Sentinel Lymph Node. Cirugía Española (English Edition), 100, 81-87. https://doi.org/10.1016/j.cireng.2022.01.003
|
[36]
|
Krag, D.N. anderson, S.J., Julian, T.B., Brown, A.M., Harlow, S.P. and Costantino, J.P. (2010) Sentinel-Lymph-Node Resection Compared with Conventional Axillary-Lymph-Node Dissection in Clinically Node-Negative Patients with Breast Cancer: Overall Survival Findings from the NSABP B-32 Randomised Phase 3 Trial. The Lancet Oncology, 11, 927-933. https://doi.org/10.1016/S1470-2045(10)70207-2
|
[37]
|
Miseré, R., van Kuijk, S., Claassens, E.L., Heuts, E.M., Pi-atkowski, A.A. and van der Hulst, R. (2021) Breast-Related and Body-Related Quality of Life Following Autologous Breast Reconstruction Is Superior to Implant-Based Breast Reconstruction—A Long-Term Follow-Up Study. Breast, 59, 176-182. https://doi.org/10.1016/j.breast.2021.07.003
|
[38]
|
Liu, J., Zheng, X., Lin, S., Han, H. and Xu, C. (2022) A Systematic Review and Meta-Analysis on the Prepectoral Single-Stage Breast Reconstruction. Supportive Care in Cancer, 30, 5659-5668.
https://doi.org/10.1007/s00520-022-06919-5
|
[39]
|
Cao, W., Xie, Y.T., He, Y.J., Li, J.F., Wang, T.F., Fan, Z.Q., Fan, T. and Ouyang, T. (2019) Risk of Ipsilateral Breast Tumor Recurrence in Primary Invasive Breast Cancer Following Breast-Conserving Surgery with BRCA1 and BRCA2 Mutation in China. Breast Cancer Research and Treatment, 175, 749-754.
https://doi.org/10.1007/s10549-019-05199-8
|
[40]
|
Valachis, A., Nearchou, A.D. and Lind, P. (2014) Surgical Management of Breast Cancer in BRCA-Mutation Carriers: A Systematic Review and Meta-Analysis. Breast Cancer Research and Treatment, 144, 443-455.
https://doi.org/10.1007/s10549-014-2890-1
|
[41]
|
Wan, Q.T., Su, L.M., Ouyang, T., Li, J.F., Wang, T.F., Fan, Z.Q., Fan, T., Lin, B.Y. and Xie, Y.T. (2021) Comparison of Survival after Breast-Conserving Therapy vs Mastectomy among Patients with or without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients with Breast Cancer. JAMA Network Open, 4, e216259.
https://doi.org/10.1001/jamanetworkopen.2021.6259
|
[42]
|
van den Broek, A.J., Schmidt, M.K., van‘t Veer Laura, J., Oldenburg Hester, S.A. and Rutgers, E.J. (2019) Prognostic Impact of Breast-Conserving Therapy versus Mastectomy of BRCA1/2 Mutation Carriers Compared with Noncarriers in a Consecutive Series of Young Breast Cancer Patients. Annals of Surgery, 270, 364-372.
https://doi.org/10.1097/SLA.0000000000002804
|
[43]
|
Su, L.M., Xu, Y., Ouyang, T., Li, J.F., Wang, T.F., Fan, Z.Q., Fan, T., Lin, B.Y. and Xie, Y.T. (2020) Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carri-ers in a Large Cohort of Unselected Chinese Breast Cancer Patients. International Journal of Cancer, 146, 3335-3342. https://doi.org/10.1002/ijc.32918
|
[44]
|
McDonnell, S.K., Schaid, D.J., Myers, J.L., Grant, C.S., Donohue, J.H., Woods, J.E., Frost, M.H. and Johnson, J.L. (2001) Efficacy of Contralateral Prophylactic Mastectomy in Women with a Personal and Family History of Breast Cancer. Journal of Clinical Oncology, 19, 3938-3943. https://doi.org/10.1200/JCO.2001.19.19.3938
|
[45]
|
Paluch-Shimon, S. (2022) ESO-ESMO Fifth International Consensus Guidelines for Breast Cancer in Young Women (BCY5). Annals of Oncology, 33, 1097-1118. https://doi.org/10.1016/j.annonc.2022.07.007
|
[46]
|
Burstein, H.J., Lacchetti, C. Anderson, H., Buchholz, T.A., Da-vidson, N.E. and Gelmon, K.A. (2019) Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. Journal of Clinical Oncology, 37, 423-438. https://doi.org/10.1200/JCO.18.01160
|
[47]
|
Gradishar, W.J. (2021) NCCN Guidelines® Insights: Breast Cancer, Version 4.2021. Journal of the National Comprehensive Cancer Network, 19, 484-493.
|
[48]
|
Zong, X., et al. (2022) Ef-fects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women with Breast Cancer in China: A Randomized Clinical Trial. JAMA Oncology, 8, 252-258.
|
[49]
|
Kummerow, K.L., Du, L., Penson, D.F., Shyr, Y. and Hooks, M.A. (2015) Nationwide Trends in Mas-tectomy for Early-Stage Breast Cancer. JAMA Surgery, 150, 9-16. https://doi.org/10.1001/jamasurg.2014.2895
|
[50]
|
Francis, P.A. (2018) Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. The New England Journal of Medicine, 379, 122-137.
|
[51]
|
Francis, P.A. (2015) Adju-vant Ovarian Suppression in Premenopausal Breast Cancer. The New England Journal of Medicine, 372, 436-446. https://doi.org/10.1056/NEJMc1502618
|
[52]
|
Cooke, A., Mills, T.A. and Lavender, T. (2010) “Informed and Un-informed Decision Making”—Women’s Reasoning, Experiences and Perceptions with Regard to Advanced Maternal Age and Delayed Childbearing: A Meta-Synthesis. International Journal of Nursing Studies, 47, 1317-1329. https://doi.org/10.1016/j.ijnurstu.2010.06.001
|
[53]
|
Moragón, S., Di Liello, R., Bermejo, B., Hernando, C., Olcina, E. and Chirivella, I. (2021) Fertility and Breast Cancer: A Literature Review of Counseling, Preservation Options and Outcomes. Critical Reviews in Oncology/Hematology, 166, Article ID: 103461. https://doi.org/10.1016/j.critrevonc.2021.103461
|
[54]
|
白宇鸽, 等. 年轻乳腺癌患者生育能力保护的研究进展[J]. 中华临床医师杂志(电子版), 2021, 15(2): 118-122.
|
[55]
|
Ronn, R. and Holzer, H. (2015) Breast Cancer and Fer-tility: An Update. Current Opinion in Supportive and Palliative Care, 9, 285-293. https://doi.org/10.1097/SPC.0000000000000164
|
[56]
|
杜娟, 马飞, 阮祥燕. 乳腺癌患者生育力保护的研究进展[J]. 中国临床医生杂志, 2019, 47(7): 769-771.
|
[57]
|
Moran, M.S., Schnitt, S.J., Giuliano, A.E., Harris, J.R., Khan, S.A., Horton, J., et al. (2014) Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer. International Journal of Radiation Oncology, Biology, Physics, 88, 553-564. https://doi.org/10.1016/j.ijrobp.2013.11.012
|